| A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Pa | Phase II | rekrutiert |
| A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Followin | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Ge | Phase II | rekrutiert |
| A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A | — | rekrutiert |
| A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa | — | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | Frühe Phase I | rekrutiert |
| A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Ref | Phase II | rekrutiert |
| A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD | Phase III | rekrutiert |
| A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Tr | Phase II | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Phase III | rekrutiert |
| A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Meta | Phase III | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia | — | rekrutiert |
| A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Trea | — | rekrutiert |
| A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate | Phase I / Phase II | rekrutiert |
| A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel | Phase I / Phase II | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD | Phase III | rekrutiert |
| A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in P | Phase III | rekrutiert |
| A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplant | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previous | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and S | Phase I | rekrutiert |
| A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome | Phase II | rekrutiert |
| A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenou | Phase III | rekrutiert |
| A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-ob | Phase II | rekrutiert |
| AUTONOMOUS DISORDERS IN CMT | — | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome | — | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF | — | rekrutiert |
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | Phase III | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| C-Brace Prospective Registry | — | rekrutiert |
| CABP2 Patient Registry and Natural History Study | — | rekrutiert |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma | — | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| CytOSorb TreatMent Of Critically Ill PatientS Registry | — | rekrutiert |
| DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig P | Phase III | rekrutiert |
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma | Phase II | rekrutiert |
| Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke | ohne Phasenangabe | rekrutiert |
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Phase III | rekrutiert |
| Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SG | Phase III | rekrutiert |
| Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participant | Phase III | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| Exercise CMR in (p)LF-LG AS | — | rekrutiert |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab i | Phase II / Phase III | rekrutiert |
| Functional Impact of Acute Respiratory Viral Infections in Older Adults | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project | ohne Phasenangabe | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German-funded Laparoscopic Approach to Cervical Cancer | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Improving Dental Care for Patients With Head and Neck Tumors | ohne Phasenangabe | rekrutiert |
| InsightRP2 Registry | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patie | Phase II | rekrutiert |
| Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating | Phase III | rekrutiert |
| LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% | Phase III | rekrutiert |
| Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies | ohne Phasenangabe | rekrutiert |
| Longitudinal Biomarkers With Selected Outcome Measures In CMT | — | rekrutiert |
| Lumbar Drainage of Intraventricular Hemorrhage | ohne Phasenangabe | rekrutiert |
| Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Tri | ohne Phasenangabe | rekrutiert |
| MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | rekrutiert |
| MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) | ohne Phasenangabe | rekrutiert |
| Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict) | — | rekrutiert |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | — | rekrutiert |
| Musicians' Health Education in D-A-CH | — | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| Observational Study Protocol: LIVER-R | — | rekrutiert |
| Oral Health in Palliative Care: A Survey Study | — | rekrutiert |
| Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathec | Phase I | rekrutiert |
| PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced N | Phase II | rekrutiert |
| Pan Tumor Rollover Study | Phase II | rekrutiert |
| Pancreatitis - Microbiome as Predictor of Severity II | — | rekrutiert |
| Pelvic Cancer Registry for Online Adapted Radiotherapy | — | rekrutiert |
| Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally | Phase II | rekrutiert |
| Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Pati | Phase III | rekrutiert |
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | Phase I | rekrutiert |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic | Phase II | rekrutiert |
| Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adu | Phase III | rekrutiert |
| Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Ca | Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mID | Phase II | rekrutiert |
| Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With D | Phase III | rekrutiert |
| Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as | Phase III | rekrutiert |
| Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for | Phase III | rekrutiert |
| Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorde | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of | Phase I / Phase II | rekrutiert |
| Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases | ohne Phasenangabe | rekrutiert |
| Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | ohne Phasenangabe | rekrutiert |
| Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) I | ohne Phasenangabe | rekrutiert |
| Prospective, Non-Randomised Clinical Trial to Investigate the BeGraft Aortic Stent Graft System | — | rekrutiert |
| Randomization of Single vs Multiple Arterial Grafts | ohne Phasenangabe | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | — | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neu | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pe | — | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| SCORE Study: Comparing Surgery and Rigid Collar Treatment for Odontoid Fractures in Adults Over | ohne Phasenangabe | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biol | Phase I / Phase II | rekrutiert |
| Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral | Phase IV | rekrutiert |
| Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antib | Phase II | rekrutiert |
| Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor | Phase III | rekrutiert |
| Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a | — | rekrutiert |
| Stroke Thrombectomy and Aneurysm Registry | — | rekrutiert |
| Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced | Phase III | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term | Phase III | rekrutiert |
| Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Im | Phase III | rekrutiert |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adult | Phase I | rekrutiert |
| TREMOR IN CHARCOT-MARIE-TOOTH | — | rekrutiert |
| TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardio | Phase III | rekrutiert |
| TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study | — | rekrutiert |
| Terumo Aortic Global Endovascular Registry | — | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) | Phase II | rekrutiert |
| This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-0682 | Phase III | rekrutiert |
| To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL | Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephali | Phase II | rekrutiert |
| Ultra-high-caloric, Fatty Diet in ALS | ohne Phasenangabe | rekrutiert |
| Using Anonymous Data From A Digital Tool for Medical History-Taking To Improve Healthcare Servic | — | rekrutiert |
| Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunothe | — | rekrutiert |
| Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metast | Phase II | rekrutiert |